-
translational environment of the UCL Institute of Neurology, the ARUK UDDI is uniquely placed to find novel targets, rapidly validate identified novel targets and mechanisms, establish screens and progress
-
translational environment of the UCL Institute of Neurology, the ARUK UDDI is uniquely placed to find novel targets, rapidly validate identified novel targets and mechanisms, establish screens and progress
-
. Research from UK DRI at UCL covers the journey from the patient to the laboratory and back to the patient with improved diagnosis, biomarkers and candidate therapies put to the test. The Hong Laboratory
-
contribute to clinics where you will review patients as part of their routine clinic visit and consent them for research. This activity may include phenotyping genetically complex patients, especially those
-
the metastatic dissemination of paediatric brain tumours, with focus on medulloblastoma. Medulloblastoma is not made up of one single type of cancer cell. Instead, it's a complex mixture of different "clones